![Michael Hanley](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Hanley
Geschäftsführer bei
ALTO NEUROSCIENCE, INC.
Vermögen: - $ am 31.08.2026
Profil
Mr. Michael C.
Hanley is a Chief Operating Officer at Alto Neuroscience, Inc. Mr. Hanley was previously employed as a Chief Business Officer by Aeglea Biotherapeutics, Inc., a Chief Commercial Officer-US & Vice President by Esteve Pharmaceuticals SA, and a Group Vice President-Marketing by Horizon Pharma Plc.
He received his undergraduate degree from Notre Dame University and an MBA from Kellogg School of Management.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 16.03.2026 | 0 ( -.--% ) | - $ | 31.08.2026 |
Aktive Positionen von Michael Hanley
| Unternehmen | Position | Beginn |
|---|---|---|
| ALTO NEUROSCIENCE, INC. | Geschäftsführer | 20.05.2024 |
Ehemalige bekannte Positionen von Michael Hanley
| Unternehmen | Position | Ende |
|---|---|---|
| SPYRE THERAPEUTICS, INC. | Corporate Officer/Principal | 14.04.2023 |
Esteve Pharmaceuticals S.A.
 Esteve Pharmaceuticals S.A. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for metabolic and endocrine system disorders & provides pharmacology research, medical care analysis and veterinary services | Corporate Officer/Principal | 01.09.2019 |
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Corporate Officer/Principal | - |
Ausbildung von Michael Hanley
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
54
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Spyre Therapeutics, Inc.
 Spyre Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company | Health Technology |
Horizon Therapeutics Ltd. (Ireland)
 Horizon Therapeutics Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Discovers, develops and manufactures pharmaceuticals for autoimmune & inflammatory diseases | Health Technology |
Notre Dame University
 Notre Dame University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kellogg School of Management
 Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Esteve Pharmaceuticals S.A.
Esteve Pharmaceuticals S.A. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for metabolic and endocrine system disorders & provides pharmacology research, medical care analysis and veterinary services | Health Technology |
Alto Neuroscience, Inc.
 Alto Neuroscience, Inc. BiotechnologyHealth Technology Engages in psychiatric drug development | Health Technology |
